NASDAQ NMS - GLOBAL MARKET · AMIX
-0.47% · -$0.0200 · Vol 32.7K
Market closed · last close 4:00 PM ET · price as of 19:56:08 ET
Autonomix Medical Inc

Autonomix Medical Inc

Health Care
$4.26
Card
Relationship Map

Follow $AMIX

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $AMIX by email

Veridion Score

BETALOW CONF · 6 of 6 factors measuredMethodology
AMIX
Autonomix Medical Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
Middle range · LOW confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: LOW · 6 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is AMIX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading AMIX catalysts
About Autonomix Medical Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2024
Employees
11
Country
US

Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.39
Day high
$4.39
Day low
$4.18
Previous close
$4.28
52W high
$26.46
-83.90% from high
52W low
$2.75
6% of range
Market cap
$8.3M
EPS
$-5.0200
Beta
5.66
Shares out
2M
Volume
32.7K
0.02× rel vol
Avg volume
1.7M
VWAP
$4.30
Price history computed in-house
1W
-2.52%
1M
-19.17%
3M
-46.59%
1Y
-80.86%
YTD
-63.12%
SMA 50 $5.73 · below
SMA 200 $8.35 · below
52W position 6%

AMIX overview

Loading financial statements
Loading AMIX Form 4 filings
Public disclosures

Congress activity in AMIX

No receipt-qualified Congressional disclosure is present for AMIX in the cached public ledger.

Federal contracts

AMIX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AMIX in this window.
Lobbying spend

AMIX lobbying filings, year to date.

Registered lobbying filings matched to Autonomix Medical Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AMIX in this window.
Loading news for AMIX
Analyst ratings
Sovereign unlock shows live analyst consensus for AMIX.
Options
Sovereign unlock shows live options positioning for AMIX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.